Imperial Brands' Buyback Execution Fails to Surprise—Market Was Already Pricing in the EPS Boost

The market's reaction to Imperial Brands' latest share buyback hinges on a simple question: was this move already expected? The answer points to a program that was largely priced in.

The company announced a £1.45 billion share repurchase programme and has already executed two phases this month, buying shares on March 5 and March 19. This isn't a surprise catalyst; it's the scheduled third leg of a pre-announced plan. The analyst consensus reflects this predictability, with a Buy rating and a £3500 price target that has remained stable. More importantly, the guidance for high-single-digit adjusted EPS growth explicitly factors in the share count reduction from this buyback. In other words, the positive impact on earnings per share was already baked into the forward view.

This sets up a classic "buy the rumor, sell the news" dynamic. The market was expecting the capital return and the resulting EPS accretion. The execution itself, therefore, is not a new positive surprise but a fulfillment of the existing plan. The expectation gap is narrow, which means the stock's movement will likely depend on whether the buyback's execution pace or price signals any change in management's confidence or capital allocation priorities. For now, the move looks like a routine step in a well-telegraphed playbook.

The Reality Check: Execution vs. Expectation

The execution of the buyback has created a classic "sell the news" setup. This wasn't a discretionary, surprise move. It was the scheduled third phase of a pre-announced £1.45 billion share repurchase programme, following two earlier phases in March. The market was expecting this capital return; the only surprise would have been if it didn't happen.

That predictability is key. The stock's price target and analyst ratings have remained stable, suggesting no significant guidance reset occurred. The consensus Buy rating and £3500.00 price target show the market is still aligned with the forward view. More importantly, the primary financial impact is a marginal adjustment from share count reduction, which is already baked into the company's own guidance. Management explicitly stated that high-single-digit adjusted EPS growth for the year is driven by both operating profit growth and this share count reduction.

In other words, the positive EPS accretion from the buyback was a priced-in component of the growth story. The execution itself, therefore, is not a new positive catalyst but the fulfillment of an existing plan. The expectation gap is narrow. For the stock to move meaningfully on this news, the execution pace or price would need to signal a change in management's confidence or capital allocation priorities-a signal that hasn't yet materialized. The reality is a routine step in a well-telegraphed playbook.

The Takeaway: Catalysts and Risks Beyond the Buyback

The buyback execution is a footnote. The real story now is about what comes next. The stock's current price hinges on two forward-looking factors: the company's ability to deliver on its new 2030 strategy and its capacity to offset persistent tobacco volume pressure.

The key catalyst is clear. This is the fifth and final year of the 2021 plan, and the company is transitioning to its next phase. Investors must now assess whether management can successfully deliver on its 2030 strategy, moving beyond the final year of its current framework. The foundation is set, with the company reporting another year of operational and financial delivery. The focus now shifts to the execution of that new roadmap, which includes building a simpler, more efficient organization and driving sustainable value in both combustibles and nicotine pouches (NGP).

The major risk, however, remains the same: continued pressure on tobacco volumes. The company has managed this through strong pricing, but that strategy has limits. The critical offset is NGP growth. The guidance calls for double-digit NGP net revenue growth this year, which is essential to broadly offset declines in key markets like Spain and the UK. Any stumble in that growth trajectory would directly threaten the company's adjusted operating profit and EPS targets.

For now, the capital allocation framework is consistent, with a £1.45 billion share buyback for FY26 announced and a commitment to ongoing returns. But investors should watch the buyback pace. A slowdown or premature halt would be a signal that management is shifting priorities, perhaps due to a change in confidence or a need to preserve cash for strategic investments. Until then, the buyback is just the expected return of capital, not a new catalyst. The stock's path will be determined by the company's ability to deliver on its 2030 promise and keep NGP scaling.